Jazz Pharmaceuticals has received a US patent for the use of Xyrem (sodium oxybate) oral solution in narcolepsy treatment. The new patent entitled Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the ...
Tags: pharmaceuticals, US patent, sodium oxybate, narcolepsy
Jazz Pharmaceuticals, a specialty pharmaceutical company, has announced the issuance of new formulation patent for Xyrem (sodium oxybate) oral solution. Xyrem (sodium oxybate) oral solution is the FDA approved product for the ...
Tags: xyrem, cataplexy, patent, pharmaceutical product